Tonix Pharmaceuticals Holding Corp (TNXP)
EBITDA
-$39.93M
Quarterly · Period ending: · USD
TNXP EBITDA
Latest reported-$39.93Mperiod ending
Latest reported-$39.93Mperiod ending
TNXP Quarterly EBITDA (-$9.05K → -$39.93M)
Quarterly EBITDA
High-resolution chart · PNG
TNXP ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -39,933,000 | |
| -39,639,000 | |
| -46,422,000 | |
| -31,548,999 | |
| -27,789,000 | |
| -16,336,000 | |
| -21,612,000 | |
| -13,703,000 | |
| -77,571,000 | |
| -13,729,000 | |
| -26,061,000 | |
| -26,759,000 | |
| -27,435,000 | |
| -32,112,000 | |
| -30,844,000 | |
| -28,729,000 | |
| -23,038,000 | |
| -26,354,000 | |
| -29,526,000 | |
| -18,518,000 | |
| -23,546,000 | |
| -20,730,000 | |
| -17,016,000 | |
| -11,991,000 | |
| -14,186,000 | |
| -7,291,000 | |
| -8,729,000 | |
| -7,886,000 | |
| -5,899,000 | |
| -6,288,000 | |
| -7,639,000 | |
| -5,528,000 | |
| -6,128,000 | |
| -6,973,000 | |
| -5,523,000 | |
| -5,819,000 | |
| -4,764,000 | |
| -5,067,000 | |
| -7,439,000 | |
| -7,575,000 | |
| -9,826,000 | |
| -13,957,000 | |
| -13,331,000 | |
| -13,235,000 | |
| -11,761,000 | |
| -9,674,000 | |
| -8,983,000 | |
| -7,428,000 | |
| -6,044,000 | |
| -5,165,000 | |
| -3,704,000 | |
| -3,088,000 | |
| -2,082,000 | |
| -1,997,000 | |
| -1,913 | |
| -1,730,266 | |
| -1,847,176 | |
| -1,110,988 | |
| -3,369,175 | |
| -1,012,132 | |
| -353,479 | |
| -511,439 | |
| -5,815 | |
| -3,685 | |
| -2,402 | |
| -5,822 | |
| -3,482 | |
| -2,613 | |
| -13,908 | |
| -10,864 | |
| -3,148 | |
| -3,652 | |
| -5,289 | |
| -9,045 |